DE
34
Projects
7
Coordinated
17
As Partner
€1,656,324
Total Budget
Budget Range
Min
€1,500
Average
€48,715
Max
€563,174
Role Distribution
Sector Distribution
Budget by Sector (€)
Projects (34)
P
EUROPEAN RARE DISEASES RESEARCH ALLIANCE
HORIZON.2.1101156595
€563,174
P
INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE
Health101112022
€99,425
P
Data-driven cancer genome interpretation for personalised cancer treatment
Health101057509
€95,843
P
Open Consortium for Decentralized Medical Artificial Intelligence
Health101057091
€86,918
P
Validation and Comparitive Multi-Omics Benchmarking of Fluid-Derived Volatilomics Biomarkers for the Prevention and Early detection of Schizophrenia
Health101156162
€79,881
P
MULTI-faceted CLIMate adaptation ACTions to improve resilience, preparedness and responsiveness of the built environment against multiple hazards at multiple scales
Climate, Energy & Mobility101123538
€74,992
P
INTEGRATING A PALLIATIVE CARE APPROACH FOR PATIENTS WITH HEART FAILURE
Health101137170
€62,074
P
Situation-aware OrchestratioN of AdapTive Architecture
Health101137507
€56,801
P
Improve Safety in Polymedication by Managing Drug-Drug-Gene Interactions
HORIZON.2.1101057639
€56,504
P
FCAECC Fellowship programme for talented researchers in cancer
MSCA (Marie Skłodowska-Curie)101081298
€42,984
P
BIOabsorbable Metallic ENDovascular Medical Devices (BIOMEND) Doctoral Network
MSCA (Marie Skłodowska-Curie)101120006
€40,398
P
Smart 4D biodegradable metallic shape-shifting implants for dynamic tissue restoration
European Innovation Council101047008
€40,395
P
ProtAct-Us from long-term consequences of road crashes
Climate, Energy & Mobility101147445
€39,995
P
Lipids as promising BRidge between novel disease InsiGHts and improved Therapy
MSCA (Marie Skłodowska-Curie)101225380
€30,170
P
DRIVIN' CAR: Developing robust in vivo nanomedicine-based chimeric antigen receptor technology
European Innovation Council101259068
€30,003
P
3D-assembly of interactive microgels to grow in vitro vascularized, structured, and beating human cardiac tissues in high-throughput
ERC (European Research Council)101043656
€29,692
P
Biomimetic Membranes for Organ Support
European Innovation Council101130006
€28,976
P
Technology-driven combinatorial therapy to rewire the spinal cord after injury
MSCA (Marie Skłodowska-Curie)101073374
€26,668
C
Multi-sensory solutions for increasing human-building resilience in face of climate change
MSCA (Marie Skłodowska-Curie)101073357
€26,558
C
Deciphering fibrosis reversal mechanisms in chronic blood cancer for identification of novel predictive and therapeutic strategies
HORIZON.1.1101124542
€19,993
C
Identification of novel diagnostic, predictive and therapeutic strategies in chronic kidney disease
HORIZON.1.1101043403
€19,991
C
Decoding diabetic kidney disease
ERC (European Research Council)101040726
€17,833
P
Discovering Collagen I degradation process in chronic diseases with fibrotic component
MSCA (Marie Skłodowska-Curie)101072828
€16,489
C
Synergistic Agent for General Medical AI
ERC (European Research Council)101222556
€15,000
C
Development of an Advanced Airway-On-A-Chip Model to Investigate Neuronal Hypersensitivity in Chronic Cough
HORIZON.1.1101162607
€14,988
P
Multifunctional Platform Technology for Magnetically Actuated Controlled Drug Release from Biodegradable Scaffolds
HORIZON.1.1101076174
€14,953
C
B Cell Engineering and Tertiary Lymphoid Structure Induction via Biomaterials for Cancer Immunotherapy
HORIZON.1.1101040996
€14,888
C
Dissecting renal metabolic reprogramming heterogeneity to target kidney fibrosis
MSCA (Marie Skłodowska-Curie)101146666
€1,738
C
PRodrug technology for Immunotherapy-priming via patient-friendly at-home MEtronomic dosing
HORIZON.1.1101138100
€1,500
C
Virus-Inspired Colorectal Cancer Treatment through an Orally Administered Vaccine
HORIZON.1.1101213420
€1,500
C
Disrupting the myofibroblast cell cycle to treat Kidney Fibrosis with a novel small molecule compound inhibitor (DISRUPT-KF)
ERC (European Research Council)101212974
€1,500
C
OPENing biological barriers using Shell-Engineered Shape-Adaptable Microbubble Enhancers
ERC (European Research Council)101247604
€1,500
C
Targeting kidney fibrosis by a novel myofibroblast specific small molecule inhibitor
ERC (European Research Council)101138549
€1,500
C
Engineering and Delivering B Cells Using Biomaterials against Breast Cancer
HORIZON.1.1101138825
€1,500